Otsuka: R&D ratio to revenue 2021

The research and development (R&D) ratio to the revenue of Otsuka Holdings Co., Ltd. in the fiscal year 2021 was around 16 percent, a slight increase from the previous year. Otsuka Holdings is a holding company of multiple group companies worldwide such as Otsuka Pharmaceutical Co., Ltd., Taiho Pharmaceutical Co., Ltd., and Otsuka Chemical.

Research and development (R&D) ratio to revenue of Otsuka Holdings Co., Ltd. from 2012 to 2021

Characteristic	R&D ratio
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-
-	-

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

June 2022

More information

Region

Japan

Survey time period

fiscal year 2012 to 2021; the company's fiscal year starts on January 1st and ends on December 31 of the stated year*

Special properties

consolidated data

Supplementary notes

*Due to a change in the consolidated fiscal year, fiscal 2014 (ended December 31, 2014) was a transitional period covering the nine months from April 1 to December 31, 2014.
Fiscal years until 2013 started on April 1 of the stated year and ended on March 31 of the following year. From fiscal 2015 onwards, fiscal years ended on December 31 of each year.

With effect from fiscal 2016 (ended December 31, 2016), Otsuka adopted the International Financial Reporting Standards (IFRS), on which the present disclosure information is based. Information for fiscal 2015 is also presented in line with IFRS.

Figures prior to fiscal 2015 come from the previous reporting.

Citation formats